Pathways > Oxycodone Pathway, Pharmacokinetics
Page last updated: 2024-10-06
Oxycodone Pathway, Pharmacokinetics
Proteins (4)
| Protein | Synonyms | Taxonomy |
|---|
| Cytochrome P450 3A4 | EC 1.14.14.1; 1,4-cineole 2-exo-monooxygenase; 1,8-cineole 2-exo-monooxygenase; 1.14.14.56; Albendazole monooxygenase (sulfoxide-forming); 1.14.14.73; Albendazole sulfoxidase; CYPIIIA3; CYPIIIA4; Cholesterol 25-hydroxylase; Cytochrome P450 3A3; Cytochrome | Homo sapiens (human) |
| UDP-glucuronosyltransferase 2B4 | UDPGT 2B4; UGT2B4; EC 2.4.1.17; HLUG25; Hyodeoxycholic acid-specific UDPGT; UDPGTh-1 | Homo sapiens (human) |
| UDP-glucuronosyltransferase 2B7 | UDPGT 2B7; UGT2B7; EC 2.4.1.17; 3,4-catechol estrogen-specific UDPGT; UDP-glucuronosyltransferase 2B9; UDPGT 2B9; UDPGTh-2 | Homo sapiens (human) |
| Cytochrome P450 2D6 | | Homo sapiens (human) |
Compounds (1)
| Compound | Description |
|---|
| noroxycodone | RN given for (5alpha)-isomer; metabolite of oxycodone |